Cargando…

Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies

Detalles Bibliográficos
Autores principales: Smyth, Duncan, Kyaw, Kaung Myat, Legister, Amy, MacFarlane, George, Sankar, Udayaraj Uma, Patel, Mehool, Clough, Chris, Kulendran, Angela, Mulroy, Eoin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440042/
https://www.ncbi.nlm.nih.gov/pubmed/34543933
http://dx.doi.org/10.1016/j.jns.2021.119982
_version_ 1783752629412691968
author Smyth, Duncan
Kyaw, Kaung Myat
Legister, Amy
MacFarlane, George
Sankar, Udayaraj Uma
Patel, Mehool
Clough, Chris
Kulendran, Angela
Mulroy, Eoin
author_facet Smyth, Duncan
Kyaw, Kaung Myat
Legister, Amy
MacFarlane, George
Sankar, Udayaraj Uma
Patel, Mehool
Clough, Chris
Kulendran, Angela
Mulroy, Eoin
author_sort Smyth, Duncan
collection PubMed
description
format Online
Article
Text
id pubmed-8440042
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84400422021-09-15 Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies Smyth, Duncan Kyaw, Kaung Myat Legister, Amy MacFarlane, George Sankar, Udayaraj Uma Patel, Mehool Clough, Chris Kulendran, Angela Mulroy, Eoin J Neurol Sci Article Elsevier B.V. 2021-11-15 2021-09-15 /pmc/articles/PMC8440042/ /pubmed/34543933 http://dx.doi.org/10.1016/j.jns.2021.119982 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Smyth, Duncan
Kyaw, Kaung Myat
Legister, Amy
MacFarlane, George
Sankar, Udayaraj Uma
Patel, Mehool
Clough, Chris
Kulendran, Angela
Mulroy, Eoin
Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies
title Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies
title_full Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies
title_fullStr Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies
title_full_unstemmed Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies
title_short Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies
title_sort post-covid-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (lgi-1) antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440042/
https://www.ncbi.nlm.nih.gov/pubmed/34543933
http://dx.doi.org/10.1016/j.jns.2021.119982
work_keys_str_mv AT smythduncan postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT kyawkaungmyat postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT legisteramy postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT macfarlanegeorge postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT sankarudayarajuma postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT patelmehool postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT cloughchris postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT kulendranangela postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies
AT mulroyeoin postcovid19opsoclonusmyoclonussyndromeandencephalopathyassociatedwithleucinerichgliomainactivated1lgi1antibodies